Skip to content

Additive effect of Roux-en Y Gastric Bypass to preoperative Very low calorie diet on non-alcoholic fatty liver diseases (NAFLD, NASH) - A randomized controlled trial

Additive effect of Roux-en Y Gastric Bypass to preoperative Very low calorie diet on non-alcoholic fatty liver diseases (NAFLD, NASH) - A randomized controlled trial - NASH IN RYGB

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00027810
Enrollment
150
Registered
2022-03-03
Start date
2022-04-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K75.8 E66.0

Interventions

Group 1: This Arm will receive two liver biopsies. The patients will receive RYGB on grounds of morbid obesity as recommended via guidelines. Prior to surgery and two weeks after surgery, the patient

Sponsors

Chirurgische Klinik Universitätsmedizin Mannheim
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: - Patients scheduled for RYGB - BMI >35 kg/m2 - Age equal or greater than 18 years - Age equal or lower than 65 years - NAFLD-fibrosis-Score equal or greater than -1.455 - Informed consent

Exclusion criteria

Exclusion criteria: - Secondary causes of steatosis - Daily alcohol consumption of more than 10g in female / 20g in male - Binge drinking of alkohol - Impaired mental state or language problems - Pregnancy - Expected lack of compliance

Design outcomes

Primary

MeasureTime frame
Change in NASH activity score (NAS)

Secondary

MeasureTime frame
- laboratory parameters (small blood count, AP, gamma-GT, Bilirubin, ALT, AST, Albumin, PT, Choline esterase, blood sugar, HbA1c) - change in NAS components ~ steatosis ~ lobular inflammation ~ hepatocyte ballooning - change in fibrosis - change in estimated percentage of liver fat - Body weight - NAFLD Fibrosis score - Change in Fibrosis (Kleiner Scale)

Countries

Germany

Contacts

Public ContactAlida Finze

Chirurgische Klinik, Universitätsmedizin Mannheim

alida.finze@umm.de0621 383 2225

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026